Chemical-genetic profile analysis of five inhibitory compounds in yeast
© Alamgir et al; licensee BioMed Central Ltd. 2010
Received: 28 January 2010
Accepted: 6 August 2010
Published: 6 August 2010
Chemical-genetic profiling of inhibitory compounds can lead to identification of their modes of action. These profiles can help elucidate the complex interactions between small bioactive compounds and the cell machinery, and explain putative gene function(s).
Colony size reduction was used to investigate the chemical-genetic profile of cycloheximide, 3-amino-1,2,4-triazole, paromomycin, streptomycin and neomycin in the yeast Saccharomyces cerevisiae. These compounds target the process of protein biosynthesis. More than 70,000 strains were analyzed from the array of gene deletion mutant yeast strains. As expected, the overall profiles of the tested compounds were similar, with deletions for genes involved in protein biosynthesis being the major category followed by metabolism. This implies that novel genes involved in protein biosynthesis could be identified from these profiles. Further investigations were carried out to assess the activity of three profiled genes in the process of protein biosynthesis using relative fitness of double mutants and other genetic assays.
Chemical-genetic profiles provide insight into the molecular mechanism(s) of the examined compounds by elucidating their potential primary and secondary cellular target sites. Our follow-up investigations into the activity of three profiled genes in the process of protein biosynthesis provided further evidence concerning the usefulness of chemical-genetic analyses for annotating gene functions. We termed these genes TAE2, TAE3 and TAE4 for translation associated elements 2-4.
Predicting gene function is a major goal of systems molecular biology in the post genome sequencing era. In this context, the yeast Saccharomyces cerevisiae has emerged as the eukaryotic model organism of choice for large-scale functional genomic investigations. Yeast cells have been subjected to a number of high throughput investigations such as gene expression analysis , protein-protein interaction mapping [2, 3] and synthetic genetic interaction analysis . Much knowledge relating to the functions of yeast genes has been collated but a significant number of genes are still not characterized in this model organism . Consequently, further studies are required to examine the function(s) of uncharacterized genes, and to investigate novel function(s) for genes that are not fully characterized.
Increased sensitivity of gene deletion mutant strains to inhibitory compounds has been used extensively to study gene functions [6, 7]. This approach is partly based on the theory that in general, the presence of redundant pathways compensates for genetic inactivation of a single pathway, with no phenotypic consequence . However, the inactivity of a second functionally overlapping pathway, in this case using a chemical treatment, can cause a "double hit" effect and result in a phenotypic consequence that can be scored as a reduction in the rate of growth, or a sick/sensitive phenotype [4, 9]. Similarly, such chemical-genetic profile analyses can be used to study cellular target sites of various bioactive compounds , pharmaceuticals  and herbal extracts  whose mechanisms of action are unknown.
In general, chemical sensitivity profiling of yeast gene knockouts can be studied using three complementary high throughput approaches. In the first case, deletion mutants can be grown individually in liquid cultures and their growth rates monitored spectrophotometrically using a microplate reader. The growth curve of micro-cultivated mutant strains in the presence and absence of a bioactive compound is used to determine strain sensitivity [12–14]. The second approach is based on synthetic lethality analysis on microarray (SLAM) . A pool of tagged deletion strains are grown in the presence and absence of the target compounds. Owing to the presence of a specific barcode in each mutant strain, the relative growth of each strain can be determined using microarray methodology, and sensitivity is measured on the basis of the relative growth of a specific mutant strain in the presence of other strains. The third approach concerns colonies of yeast gene deletion mutant strains being arrayed on solid media in the presence and absence of the target compounds [9, 16]. The growth rates of individual colonies are estimated by their relative colony size relative to a control. Each of these techniques has inherent advantages and disadvantages. The results obtained from these methodologies are considered to be complementary .
Recently, we showed that high throughput chemical sensitivity profile analysis of yeast gene knockout strains to paromomycin can be used to study novel gene functions, and reported that a previously uncharacterized open reading frame, TAE1, has a novel role in protein biosynthesis or translation . In the present study, colony size reduction was used to screen and analyze the yeast gene knockout collection for their sensitivity to five bioactive compounds that target the process of protein biosynthesis. We followed up by studying the activities of three profiled genes for their involvements in protein biosynthesis and termed them TAE2, TAE3 and TAE4 for translation associated elements 2-4.
Drug sensitivity screens
The entire collection of the haploid yeast gene deletion array (yGDA) (~4700) was screened for increased sensitivity to the bioactive compounds cycloheximide, 3-amino-1,2,4-triazole (3-AT), paromomycin, streptomycin and neomycin. These drugs have reported involvement in protein biosynthesis or translation. Cycloheximide is a glutarimide antibiotic that binds to the 60 S ribosomal subunit and inhibits translation elongation . 3-AT is a competitive inhibitor of imidazole glycerol phosphate dehydratase, an enzyme involved in the biosynthesis of the amino acid histidine , and causes amino acid starvation . Paromomycin, neomycin and streptomycin are known to bind the small ribosomal subunit of eukaryotic cells, inhibit ribosomal translocation and compromise translation fidelity . We hypothesized that sensitivity to these drugs could be used as a method of identifying new genes associated with the process of protein biosynthesis. Sub-inhibitory concentrations of the drugs were used in this study. Under these growth conditions only strains with increased sensitivity would demonstrate growth reduction and the growth of the remaining strains would be largely unaffected. Each experiment was repeated three times and the total number of analyses exceeded 70,000. We have previously reported analysis concerning sensitivity to paromomycin . Here, we present the collective analysis of the total data from the entire collection of sensitive strains.
Colony size (CS) measurement was used to determine sensitivity. The relative colony growths (normalized to the average growth on the plate) on treated plates were compared with those grown under control conditions (untreated) as described previously . CS measurement is an established method used to identify drug sensitive strains [9, 16, 24] and is reported to identify approximately 63% of sensitive strains detected by standard large-scale spot test (ST) analysis . Therefore, a number of sensitive strains that could be detected using ST analysis may not have been detected using CS, indicating that our approach using CS to identify sensitivity is not exhaustive. Furthermore, it is reported that 59% of the sensitive strains detected by CS are not detected by ST and hence may represent novel/false positives.
To reduce false positive results, gene deletion strains with sensitivity to different unrelated bioactive compounds that we continuously observed in our previous independent screens, as well as those reported by others , were eliminated from the list of sensitive strains. These genes typically represent multiple-drug resistant genes that are not linked to the cellular target sites of the drugs of interest. Inclusion of these genes would complicate the analysis of the molecular activity of the target compounds. The final list of the genes that when deleted increased drug sensitivity to the tested bioactive compounds is presented in Additional file 1. There are 383, 320, 205, 99 and 89 genes that, when deleted, confer increased sensitivity to cycloheximide, 3-AT, streptomycin, neomycin and paromomycin, respectively. These are non-essential genes that are normally not required for the growth of yeast cells under typical laboratory conditions, suggesting that the slow growth phenotype of the corresponding deletion strains is a direct result of the inhibitory effects of the target drugs. Cycloheximide, streptomycin, neomycin and paromomycin bind to ribosomes and cause defects in protein synthesis [26, 27]. Therefore, as expected, among gene deletion strains with increased sensitivity to these drugs, we identified numerous previously characterized protein synthesis related genes including ribosomal protein L27A gene YHR010W (RPL27A), translation initiation factor YJL138C (TIF2), tRNA methyltransferase YDL201W (TRM8), mitochondrial translation initiation factor YOL023W (IFM1) and eIF4E-associated gene EAP1 (YKL204W).
Smaller clusters could represent additional target sites (side effects) of the drugs. For example, neomycin is known to inhibit the phospholipase C pathway and thus interfere with signal transduction in eukaryotic cells . This could explain the observation that deletion of YIL050W (PCL7), which codes for a member of a metabolism-associated Pho85c kinase complex, confers cell sensitivity to neomycin. The smaller clusters could also represent novel secondary functions for certain genes, some of which may link translation to other cellular processes. For example, deletion of YER095W (RAD51) or YOL090W (MSH2) increased sensitivity to cycloheximide. YER095W and YOL090W are involved in repair of DNA strand breaks. Interestingly, YER095W is reported to have a genetic interaction (positive genetic) with the translation termination factor eRF3 gene YDR172W (SUP35) and the translation elongation factor YLR249W (YEF3) gene , and its product is reported to interact physically with glutamyl tRNA synthetase protein, YGL245Wp (Gus1p) . Similarly, the gene product of YOL090W is reported to interact physically with the translation initiation factor eIF4A, YJL138C (TIF2) . This is in agreement with the recently reported link between DNA damage response and translation . Alternatively, the smaller clusters could represent false positive results. However, the most likely scenario is that each of the aforementioned cases represents a different integrated part of the data. For example, secondary target sites of a drug can be investigated with the prior knowledge that the smaller clusters could contain genes with novel secondary functions as well as a number of false positives. An interesting observation is that the overall distribution of genes within each functional cluster was similar for each of the five drugs investigated herein (Figure 1A). This could represent cross-talk between protein synthesis and the other four cellular processes. Based on our previous observations of chemical-genomic profiles of other inhibitory compounds with diverse modes of action such as calcoflour white, methyl methane sulfate, and sodium dodecyl sulfate, the profiles presented in Figure 1A are distinct (unpublished data).
As utilized previously , a hierarchical clustering approach to drug sensitivity was used to analyze the chemical profiles (Figure 1B). It is expected that compounds with similar modes of activity have similar profiles with considerable overlaps, and hence cluster together. As expected, the profiles for paromomycin and neomycin had considerable overlaps and hence these compounds were clustered together by hierarchical clustering using complete linkage. These aminoglycosides bind small ribosomal subunits and compromise translation fidelity and translocation. Cycloheximide and 3-AT also had considerable overlaps and were clustered together as expected; these drugs can affect the elongation phase of translation. Cycloheximide does so by binding the 60 S ribosomal subunit  whereas 3-AT causes starvation of amino acids needed for successful elongation. Interestingly, streptomycin, an aminoglycoside, had more overlap and was more closely associated with cycloheximide and 3-AT. Unlike other aminoglycosides, streptomycin does not bind the ribosomal A-site , implying that streptomycin binding to the ribosome could result in an alternative ribosomal conformation that resembles the action of cycloheximide and 3-AT. The effect of streptomycin on prokaryotic translation elongation, which is different from other aminoglycosides, is well documented .
The overlap of strain sensitivities to different drugs is represented in Figure 1C. A total of 1519 gene deletion mutants were identified with increased sensitivity to a minimum of one drug (Figure 1C); 408 were sensitive to two or more drugs. A mutant for the vacuole gene YDR495CΔ (vps3Δ) was sensitive to the five treatments. This mutant has been observed in other screens, suggesting non-specific involvement in multiple drug resistance. When analyzing the overlapping drug sensitive strains, the ratio of protein synthesis related genes did not increase significantly when sensitivities to two or more drugs were analyzed (Figure 1C and 1D and Additional file 1). Enrichment in the category of transport and stress related genes, into which multiple drug resistant genes generally fall, was observed for some multiple drug sensitive groups. This highlights that selection based on several drugs could partially target multiple drug resistant genes.
Synthetic genetic array (SGA) analysis for TAE2, TAE3 and TAE4
The majority of mutants with increased sensitivity to the target drugs had deletions of genes with known functions in protein biosynthesis. Therefore, the activities of three mutants for genes that are not well characterized, YPL009C, YIL137C and YPL183W-A, were examined by studying genetic interactions with previously reported protein biosynthesis related genes. These genes have not been characterized but available literature and our unpublished data suggest possible associations with certain disease related-genes and phenotypes (see Discussion).
In addition, some of the identified genetic partners were shared between the query genes (Figure 3). For example, YDR025W, which codes for the small ribosomal subunit protein S11A, interacted genetically with TAE2 and TAE4, and YFR009W (GCN20), which is involved in positive activation of GCN2 kinase, interacted with TAE3 and TAE4. Furthermore, a synthetic genetic interaction between TAE2 and TAE4 was observed.
In contrast to the aggravating interactions in which sickness of double mutants was investigated, interactions concerning double mutants with higher fitness than expected were examined. Such alleviating interactions, also known as synthetic rescue, are thought to exist between genes in the same pathway . Six such interactions were identified in this study (Figure 3). In agreement with the synthetic sickness interactions, which showed that the largest functional interaction partners for TAE3 and TAE4 were involved in translation associated RNA processing, it was observed that TAE3 interacted with the RNA processing gene YLR107W (REX3) and with YKL068W (NUP100), a gene involved in RNA transport from the nucleus and associated with rRNA and tRNA export, and that TAE4 interacted with another RNA processing gene, YNL001W (DOM34). TAE2 had alleviating interactions with three genes with different functions, namely YKR059W (TIF1), which has a role in translation initiation, YDR494W (RSM28), which is involved in mitochondrial translation, and YDR450W (RPS18A), associated with the structure of small ribosomal subunits. The diversity of the interactions in which TAE2 is involved mirrors the results of the synthetic sick interactions, leading to the conclusion that it did not interact with one major functional group.
A recent genome-wide synthetic genetic interaction study used TAE3 and TAE4 as query genes and demonstrated that they formed synthetic sick and lethal interactions predominantly with genes involved in protein biosynthesis (P-values of 10-7 and 10-16 for TAE3 and TAE4, respectively) , confirming the results presented herein. Similarly, the synthetic sick and lethal interactions reported for TAE2 predominantly (P-value = 0.003) concerned protein biosynthesis genes.
Functional correlations for TAE2 and TAE4 with other protein synthesis related genes
As was the case with the synthetic genetic interactions for TAE2, the phenotypic suppression analysis suggested a general role for TAE2 in translation. Overexpression of TAE2 compensated for the deletion of a number of genes with diverse roles in translation such as YMR242C (RPL20A), which codes for a 60 S ribosomal subunit protein, YDR462W (MRPL28), which codes for a mitochondrial ribosome protein, and YKR059W (TIF1), which codes for the translation initiation factor eIF4A.
Three of the rescued gene deletion strains, YDL083CΔ (rps16BΔ), YPL081W Δ (rps9AΔ) and YIL052C Δ (rpl34BΔ), were shared between TAE2 and TAE4. This is in accordance with the synthetic genetic interaction observed between these two genes (Figure 3). Such interactions highlight the interconnectivity of a genetic interaction map for translation genes.
Deletions of TAE2, TAE3 and TAE4 affect the process of protein synthesis
The genetic interaction analyses provide a direct link between TAE2, TAE3 and TAE4, and the process of protein biosynthesis. To investigate this link further we examined the effect of deletion of the target genes on translation efficiency, stop codon readthrough and ribosome biogenesis. If any differences were detected we would expect them to be subtle owing to the importance of protein biosynthesis for cell survival and the fact that the deletion of the target genes does not change the growth rate of the mutants under standard laboratory conditions.
A plasmid-based β-galactosidase system with different premature termination codons was used to study stop codon readthrough. In this approach alterations in translation fidelity lead to an increase in termination codon readthrough and thus elevate the production of full length functional β-galactosidase. To this end, target deletion strains were transformed with three different plasmids, pUKC815, pUKC817and pUKC818 , and the expression of β-galactosidase in each mutant was quantified. pUKC815 contains no in-frame premature termination codon and was used as a control. pUKC817 and pUKC818 contain in-frame termination codons UAA and UAG, respectively. Apparent from the increased relative productions of β-galactosidase shown in Figure 5C, deletion of TAE2, TAE3 and TAE4 resulted in higher levels of termination codon readthrough. Comparable levels of β-galactosidase mRNA were evident in each of the tested strains (data not shown) demonstrating that the observed increase s in β-galactosidase activity were not due to altered levels of mRNA.
A surprising observation was that deletion of TAE4 resulted in a higher readthrough for the UAA (pUKC817) stop codon but not UAG (pUKC818). Generally, it is expected that alterations in translation fidelity result in more readthrough for a less stringent stop codon, in this case UAG. This was observed for tae2 Δ and tae3 Δ but not tae4 Δ. A possible explanation is that deletion of TAE4 causes an alteration that is stop codon specific. For example, it could reduce the affinity of ribosomes for a specific translation release factor (RF) but not others.
Next, the ribosome profiles for tae2 Δ, tae3 Δ and tae4 Δ gene deletion strains were investigated. The profiles had three peaks associated with free 40 S and 60 S subunits and 80 S monosomes, followed by a series of peaks representing polysomes (Figure 5D). The ribosome profile for tae2 Δ was comparable to the wild type strain (data not shown). However, for tae3 Δ, a reduction in polysomes was observed, as was an increase in free 60 S subunit (Figure 5D). The free 60S:40 S subunit ratio for this mutant was 2.94 ± 0.51 in comparison to 1.77 ± 0.29 for the wild type. Similarly, the profile for tae4 Δ demonstrated a significant increase in free 60 S subunits, a slight increase in 80 S monosomes and a slight reduction in larger polysomes (Figure 5D). The free 60S:40 S subunit ratio for tae4 Δ was 5.34 ± 0.71. Reduction of polysomes could explain the observed reductions in the efficiency of protein synthesis for tae3 Δ and tae4 Δ. Alterations in the pool of free ribosomal subunits could relate to deficits in subunit biogenesis, suggesting that TAE3 and TAE4 could be involved in the process of ribosome biogenesis. The 40 S and 60 S subunits are in equilibrium with 80 S monosomes, therefore an increase in 60 S free subunits could relate to a defect in 40 S biogenesis  as observed for tae3 Δ and tae4 Δ mutants. A more precise calculation for measuring free 60S:40 S involves measuring 40 S and 60 S subunits separated on a sucrose gradient with low concentrations of Mg2+, but this was not carried out in the present study.
Gene deletions that cause increased sensitivity to a bioactive compound can be used to identify pathways that buffer the cell against the activity of that compound . Therefore, chemical-genetic profiles of inhibitory compounds can lead to identification of their overall mode of action and any side effects associated with toxicity of the drug. Furthermore, these profiles can help identify novel genes involved in specific cellular pathways targeted by compounds . In this study the sensitivity of a yeast gene deletion array to five different bioactive compounds was investigated using colony size reduction as the endpoint. The overall profiles of these compounds were comparable, with the deletion of genes involved in protein biosynthesis being the dominant cluster. Further investigations concerned three sensitive deletion strains for genes that are not well characterized, that here we term TAE2, TAE3 and TAE4. Genetic analyses provided evidence for involvement of these genes in protein biosynthesis.
There is limited information relating to the molecular activity of Tae4p. In a large-scale investigation it was reported that deletion of TAE4 rescued the temperature sensitivity of cdc13-1, so it was thought to be a restrictor of telomere capping; Cdc13p is an essential protein involved in checkpoint and telomere capping. The C-terminal domain of Tae4p, amino acids 56-93, has sequence homology to the prokaryotic ribosomal protein L36. In the current study it was observed that TAE4 formed synthetic sick interactions with two predominant categories of genes with functions in RNA processing associated with protein biosynthesis and genes that code for 40 S ribosomal subunit associated proteins. Furthermore, it formed phenotypic suppression interactions with the same two categories of genes, linking the activity of TAE4 to RNA processing and the 40 S subunit. TAE4 involvement in 40 S biogenesis was confirmed by ribosome profile analysis and explains the observed effects of the deletion of TAE4 on stop codon readthrough and the efficiency of translation. Furthermore, TAE4 is co-regulated with several rRNA processing proteins such as the LSM protein YJR022Wp (Lsm8p) implicated in pre-rRNA and pre-tRNA processing  and a preribosome processing protein YLR409Cp (Utp21p) involved in 18 S rRNA processing . These observations, together with the results presented here, provide strong evidence that the activity of TAE4 is related to RNA processing and ribosome biogenesis. The C-terminal domain of Tae4p contains two RNA binding domains. Therefore, Tae4p can affect rRNA processing by directly binding to rRNA or by recruiting other factors to rRNA, which in turn can affect ribosome biogenesis.
TAE2 (YPL009C) has no previously reported cellular function but its protein product shares a domain similar to the human colon cancer antigen 1 (SDCCAG1) and has some sequence homology with a putative RNA binding protein in Drosophila melanogaster. The synthetic sick and synthetic rescue genetic interaction analyses presented herein indicated a diverse interaction pattern for TAE2 with various translation genes. TAE2 overexpression rescued the phenotype of deletion strains for genes with different functions in various steps of translation, suggesting a general involvement of TAE2 in protein biosynthesis that is not targeted to a specific pathway. Deletion of TAE2 caused an increase in stop codon readthrough and a decrease in translation efficiency. One possible explanation for these results is that TAE2 could transiently aid in mediating the overall activity of ribosomes and hence translation efficiency and fidelity. Translation in vivo is more efficient than in reconstituted in vitro experiments, indicating the presence of uncharacterized translation elements in vivo . The activity of TAE2 is supported by the observation that in large-scale affinity purification experiments Tae2p co-purified with several ribosomal subunit proteins . However, low concentrations of salt destabilize this interaction  suggesting that Tae2p transiently interacts with ribosomes. In addition, Tae2p was recently computationally predicted to interact directly with the ribosomal subunit protein YDR418Wp (Rpl2Bp) .
TAE3 predominantly formed synthetic sick interactions with RNA processing genes involved in translation and formed synthetic rescue interactions with genes with similar RNA processing functions. Alterations in the ribosomal profile of the tae3 Δ strain suggest a deficiency in 40 S subunit biogenesis, and a role for TAE3 in RNA processing associated with 40 S biogenesis could explain these observations. In addition, this would explain the observation that deletion of TAE3 caused an increased stop codon readthrough and a reduction in the efficiency of protein synthesis. In agreement with this role for TAE3, the expression of TAE3 is reported to be strongly co-regulated with essential translation genes including YAL003W (FUN53), which codes for a subunit of RNase MRP involved in pre-rRNA cleavage, and YBL004W (UTP20), which is involved in 18 S rRNA processing . Tae3p does not appear to contain an RNA binding domain. Therefore, it is possible that Tae3p may interact with an intermediate RNA binding protein(s) in order to exert its activity. In agreement with this, Tae3p was reported to co-purify with YOR272Wp (Ytm1p), a constituent of the 66 S pre-ribosomal particle . In addition, we previously observed that deletion of TAE3 reduced the efficiency of double stranded DNA break repair, which could be an independent activity for TAE3 (unpublished data).
The effect of TAE3 deletion on stop codon readthrough is in agreement with a previous study . However, the same investigation detected no apparent alteration in translation efficiency. A possible explanation for this difference is that the latter study utilized diploid homozygous gene deletion cells whereas the current study used haploid cells and the efficiency of induced translation was not measured in the former. Differences between the experimental observations in the haploid and diploid systems have been reported .
The overall chemical-genetic profiles of the investigated compounds were comparable, with genes associated with protein biosynthesis being the dominant cluster, followed in a broad descending order by those involved in metabolism, cellular compartments and biogenesis, transport and stress, DNA repair and replication, and others. This observation may further underline previously speculated links between protein biosynthesis and other fundamental cellular processes. The smaller clusters could also represent alternative modes of activities for these compounds. Genetic investigations of three profiled genes further highlighted the effectiveness of chemical-genetic profiling for the investigation of gene functions for translation genes.
Standard rich (YPD) and synthetic complete (SC) media were used for the experiments . Yeast cells were grown at 30°C for 1-2 days. The YPD medium containing Geneticin (G418; 200 μg/ml) was used for the maintenance of deletion strains carrying the G418r marker. To investigate the effects of drugs on the growth of yeast deletion mutants, paromomycin (10 mg/ml), streptomycin (40 mg/ml), neomycin (5.5 mg/ml) and 3-AT (22 mg/ml) were added to SC medium and cycloheximide (45 ng/ml) was added to YPD medium. G418 sulfate, cycloheximide and 3-AT were purchased from Sigma and paromomycin sulfate from Fluka. Neomycin sulfate and streptomycin were obtained from Bioshop, Canada.
Drug sensitivity analysis
MIC for each compound was measured as the lowest drug concentration that resulted in inhibition of visible growth of yeast strains on sterile 96-well microtitre plates. A standard protocol was used . Serial dilutions of the compounds were added to the test microtitre plates. Plates were incubated at 30°C for 1-2 days. Inhibition of growth was visually compared with control wells containing no drugs.
The relative size of colonies calculated in this way was used to determine relative growth differences for each colony under different experimental conditions (that is, treated versus control); each experiment was repeated three times. Colonies that demonstrated 30% or more reduction in two replicates, or those with an average reduction of more than 20% (with internal variation of 20% or less) in all three experiments, were classified as "hits" or sensitive colonies.
Sensitivities of selected mutant strains identified in primary screens were confirmed by spot test analysis. Yeast cells were grown in YPD or SC liquid media to mid-log phase and diluted to a concentration of 10-3 to 10-6 cells/20 μl. From each dilution, 20 μl was spotted on to medium containing sub-inhibitory concentrations of the drugs or without drugs (control). The growth patterns were compared after 1-2 days at 30°C as described by Jessulat et al. . Each experiment was repeated a minimum of three times.
High throughput synthetic genetic interaction and phenotypic suppression analysis
Gene deletions in the Matα (Y7092) strain were generated by PCR-based gene targeting . The 5'- and 3'-flanking regions of the target gene (55 bp for either end) and nourseothricin (NAT) resistance marker  were amplified. The PCR product was directly used to transform yeast cells. Transformants were selected on YPD medium containing 150 μg/ml NAT. Proper integration of the deletion cassette was confirmed by PCR.
Synthetic genetic array analyses were carried out as described previously . Briefly, each query strain carrying a target gene deletion in a MATα background was crossed with a set of 384 yeast deletion mutants (MATa) known to be involved in translation. Diploids were sporulated and the resulting haploids were grown on selective plates. After several selection steps, MATa haploids carrying double gene mutations were selected. The sickness of double gene mutants was evaluated by comparing their relative quantified growth (colony size) with those for single gene mutant strains using GD software . For synthetic sickness, growth differences of 30% or more were selected as positive. For alleviating interactions, growth differences of 20% or more were selected. The identified synthetic genetic interactions were confirmed by random spore analysis .
Gene overexpression constructs are described by Sopku et al. . Suppression analysis was performed as before . Briefly, overexpression plasmids were transformed into a MATα strain. The transformed strains were crossed with a set of yeast gene deletion strains for 384 translation genes as above. The sensitivities of yeast strains containing the overexpression constructs were compared to those with a control plasmid or no plasmid, against neomycin and streptomycin, using colony size measurements. A cut off value of 30% or more was used.
Alterations in translation fidelity were measured using plasmids pUKC817 and pUKC818, which carry the premature stop mutations UAA and UGA, respectively, in a β-galactosidase expression cassette. pUKC815 contains no premature stop codon and was used as a control. β-galactosidase was assayed using O-nitrophenyl-α-D-galactopyranoside (ONPG) as described previously  with some modification. Briefly, mutant cells were grown overnight in minimal media. Subcultures were grown to the exponential phase (OD600 ~1.0), cells were collected by centrifugation and were resuspended in Z-buffer. The units of enzyme activity were calculated as nanomoles and represent the level of ONPG hydrolyzed per microgram of total protein . All assays were conducted in triplicate. Real-time PCR analysis was performed using Rotor Gene RG-300 from Corbett Research as described . Yeast total RNA was isolated using a Bio-Rad total RNA extraction kit. The total RNA was quantified by monitoring absorbance at 260 nm. cDNA was synthesized using 0.5 μg of total extracted RNA from each of the strains using reverse transcriptase (Bio-Rad) according to the manufacturer's instructions at 42°C for 45 min, and the reaction was stopped by 5 min incubation at 85°C.
The rate of total protein synthesis was evaluated in vivo by measuring the incorporation of [35S] methionine into the cellular proteins as previously described by Schwartz and Parker  with modifications. Briefly, yeast strains were grown to mid-log phase at 30°C in YPD. The cells were harvested, resuspended in pre-warmed minimal medium lacking methionine, and supplemented with 10 μCi/ml of [35S] methionine. The cells were incubated for 1 h at 30°C and harvested by centrifugation. The samples were washed with distilled water six times and 2 μl aliquots were collected on Whatman paper. The paper was air dried and exposed to storage phosphor screen for 1 h. The amount of radioactivity incorporated into total cellular proteins was measured by a Cyclon storage phosphor screen reader. Each experiment was repeated at least five times. Induced translation was measured using an inducible β-galactosidase reporter gene in p416  plasmid after 4 h induction.
Polysome preparations were obtained according to the protocol of Foiani et al. . Haploid yeast mutant and wild type strains were grown on YPD at 30°C to an OD600 of 0.8-1.0, and to a density of 2 × 107 cells/ml. Immediately, 200 μl of cycloheximide (50 μg/ml) was added, and each culture was quickly chilled in an ice water bath. Cells were harvested, washed and centrifuged at 4000 rpm for 4 min at 4°C using a Sorvall SLA-1500 rotor to separate the supernatant. Cell pellets were resuspended in 10 ml of ice-cold breaking buffer A (YA buffer: 10 mM Tris-HCl [pH 7.4], 100 mM NaCl, 30 mM MgCl2, cycloheximide 50 μg/ml, heparin 200 μg/ml) and centrifuged at 4000 rpm for 4 min at 4°C (Sorvall SS34 rotor) twice. Pellets were resuspended in 0.5 ml of YA buffer, lysed by vortexing with glass beads and stored at -80°C. Twenty OD260 units of each supernatant were fractionated on 8-48% sucrose gradients containing 50 mM Tris-acetate (pH 7.0), 50 mM NH4Cl, 12 mM MgCl2, and 1 mM dithiothreitol. The extract was centrifuged for 2.5 h at 39,000 rpm using a SW40-Ti rotor in a Beckman LE-80 K at 4°C. The polysome profiles were analyzed by monitoring the absorbance at 254 nm in a Beckman spectrophotometer.
yeast non-essential Gene Deletion Array
Translation Associated Element
3-amino-1, 2, 4-triazole.
The authors would like to thank Dr. Mick Tuite (University of Kent at Canterbury) and Dr. Terri Goss Kinzy (University of Medicine and Dentistry of New Jersey) for their generous gifts of pUKC-based plasmids. Many thanks go to Chris Kiani and Ben Laliberte for excellent technical assistance and Joanna Freedman for excellent editorial work. This work is supported by a grant from Natural Sciences and Engineering Research Council of Canada (NSERC). This work is dedicated to the loving memory of Moluk "Joghdi" Saleh.
- Ghaemmaghami S, Huh WK, Bower K, Howson RW, Belle A, Dephoure N, O'Shea EK, Weissman JS: Global analysis of protein expression in yeast. Nature. 2003, 425: 737-741. 10.1038/nature02046.View ArticlePubMed
- Ito T, Chiba T, Ozawa R, Yoshida M, Hattori M, Sakaki Y: A comprehensive two-hybrid analysis to explore the yeast protein interactome. Proc Natl Acad Sci USA. 2001, 98: 4569-4574. 10.1073/pnas.061034498.PubMed CentralView ArticlePubMed
- Uetz P, Giot L, Cagney G, Mansfield TA, Judson RS, Knight JR, Lockshon D, Narayan V, Srinivasan M, Pochart P, Qureshi-Emili A, Li Y, Godwin B, Conover D, Kalbfleisch T, Vijayadamodar G, Yang M, Johnston M, Fields S, Rothberg JM: A comprehensive analysis of protein-protein interactions in Saccharomyces cerevisiae. Nature. 2000, 403: 623-627. 10.1038/35001009.View ArticlePubMed
- Tong AHY, Evangelista M, Parsons AB, Xu H, Bader GD, Pagé N, Robinson M, Raghibizadeh S, Hogue CWV, Bussey H, Andrews B, Tyers M, Boone C: Systematic genetic analysis with ordered arrays of yeast deletion mutants. Science. 2001, 294: 2364-2368. 10.1126/science.1065810.View ArticlePubMed
- Peña-Castillo L, Hughes TR: Why are there still over 1000 uncharacterized yeast genes?. Genetics. 2007, 176: 7-14. 10.1534/genetics.107.074468.PubMed CentralView ArticlePubMed
- Chloupková M, LeBard LS, Koeller DM: MDL1 is a high copy suppressor of ATM1: evidence for a role in resistance to oxidative stress. J Mol Biol. 2003, 331: 155-165. 10.1016/S0022-2836(03)00666-1.View ArticlePubMed
- Lesage G, Sdicu A, Ménard P, Shapiro J, Hussein S, Bussey H: Analysis of beta-1,3-glucan assembly in Saccharomyces cerevisiae using a synthetic interaction network and altered sensitivity to caspofungin. Genetics. 2004, 167: 35-49. 10.1534/genetics.167.1.35.PubMed CentralView ArticlePubMed
- Hartman JL, Garvik B, Hartwell L: Principles for the buffering of genetic variation. Science. 2001, 291: 1001-1004. 10.1126/science.291.5506.1001.View ArticlePubMed
- Parsons AB, Brost RL, Ding H, Li Z, Zhang C, Sheikh B, Brown GW, Kane PM, Hughes TR, Boone C: Integration of chemical-genetic and genetic interaction data links bioactive compounds to cellular target pathways. Nat Biotechnol. 2004, 22: 62-69. 10.1038/nbt919.View ArticlePubMed
- Baetz K, McHardy L, Gable K, Tarling T, Reberioux D, Bryan J, Anderson RJ, Dunn T, Hieter P, Roberge M: Yeast genome-wide drug-induced haploinsufficiency screen to determine drug mode of action. PNAS. 2004, 101: 4525-4530. 10.1073/pnas.0307122101.PubMed CentralView ArticlePubMed
- Galván IJ, Mir-Rashed N, Jessulat M, Atanya M, Golshani A, Durst T, Petit P, Amiquet VT, Boekhout T, Summerbell R, Cruz I, Arnason JT, Smith ML: Antifungal and antioxidant activities of the phytomedicine pipsissewa, Chimaphila umbellata. Phytochemistry. 2008, 69: 738-746. 10.1016/j.phytochem.2007.09.007.View ArticlePubMed
- Warringer J, Ericson E, Fernandez L, Nerman O, Blomberg A: High-resolution yeast phenomics resolves different physiological features in the saline response. Proc Natl Acad Sci USA. 2003, 100: 15724-15729. 10.1073/pnas.2435976100.PubMed CentralView ArticlePubMed
- Warringer J, Anevski D, Liu B, Blomberg A: Chemogenetic fingerprinting by analysis of cellular growth dynamics. BMC Chem Biol. 2008, 8: 3-10.1186/1472-6769-8-3.PubMed CentralView ArticlePubMed
- Engler KH, Coker R, Evans IH: A novel colorimetric yeast bioassay for detecting trichothecene mycotoxins. J Microbiol Methods. 1999, 35: 207-21. 10.1016/S0167-7012(98)00119-5.View ArticlePubMed
- Ooi SL, Shoemaker DD, Boeke JD: DNA helicase gene interaction network defined using synthetic lethality analyzed by microarray. Nat Genet. 2003, 35: 277-286. 10.1038/ng1258.View ArticlePubMed
- Davis-Kaplan SR, Ward DM, Shiflett SL, Kaplan J: Genome-wide analysis of iron-dependent growth reveals a novel yeast gene required for vacuolar acidification. J Biol Chem. 2004, 279: 4322-4329. 10.1074/jbc.M310680200.View ArticlePubMed
- Pan X, Yuan DS, Xiang D, Sookhai-Mahadeo XS, Bader JS, Hieter P, Spencer F, Boeke JD: A robust toolkit for functional profiling of the yeast genome. Mol cell. 2004, 16: 487-496. 10.1016/j.molcel.2004.09.035.View ArticlePubMed
- Alamgir M, Eroukova V, Jessulat M, Xu J, Golshani A: Chemical-genetic profile analysis in yeast suggests that a previously uncharacterized open reading frame, YBR261C, affects protein synthesis. BMC Genomics. 2008, 9: 583-10.1186/1471-2164-9-583.PubMed CentralView ArticlePubMed
- Schneider-Poetsch T, Ju J, Eyler DE, Dang Y, Bhat S, Merrick WC, Green R, Shen B, Liu JO: Inhibition of eukaryotic translation elongation by cycloheximide and lactimidomycin. Nat Chem Biol. 2010, 6: 209-217. 10.1038/nchembio.304.PubMed CentralView ArticlePubMed
- Hinnebusch AG: Translational regulation of GCN4 and the general amino acid control of yeast. Annu Rev Microbiol. 2005, 59: 407-450. 10.1146/annurev.micro.59.031805.133833.View ArticlePubMed
- Zhou W, Edelman GM, Mauro VP: Isolation and identification of short nucleotide sequences that affect translation initiation in Saccharomyces cerevisiae. Proc Natl Acad Sci USA. 2003, 100: 4457-4462. 10.1073/pnas.0437993100.PubMed CentralView ArticlePubMed
- Tuite MF, McLaughlin CS: The effects of paromomycin on the fidelity of translation in a yeast cell-free system. Biochim Biophys Acta. 1984, 783: 166-170.View ArticlePubMed
- Memarian N, Jessulat M, Alirezaie J, Mir-Rashed N, Xu J, Zareie M, Smith M, Golshani A: Colony size measurement of the yeast gene deletion strains for functional genomics. BMC Bioinformatics. 2007, 8: 117-10.1186/1471-2105-8-117.PubMed CentralView ArticlePubMed
- Parsons AB, Lopez A, Givoni IE, Williams DE, Gray CA, Porter J, Chua G, Sopko R, Brost RL, Ho CH, Wang J, Ketela T, Brenner C, Brill JA, Fernandez GE, Lorenz TC, Payne GS, Ishihara S, Ohya Y, Andrews B, Hughes TR, Frey BJ, Graham TR, Andersen RJ, Boone C: Exploring the mode-of-action of bioactive compounds by chemical-genetic profiling in yeast. Cell. 2006, 126: 611-625. 10.1016/j.cell.2006.06.040.View ArticlePubMed
- Hillenmeyer ME, Fung E, Wildenhain J, Pierce SE, Hoon S, Lee W, Proctor M, St Onge RP, Tyers M, Koller D, Altman RB, Davis RW, Nislow C, Giaever G: The chemical genomic portrait of yeast: uncovering a phenotype for all genes. Science. 2008, 320: 362-365. 10.1126/science.1150021.PubMed CentralView ArticlePubMed
- Wang X, Zuo X, Kucejova B, Chen XJ: Reduced cytosolic protein synthesis suppresses mitochondrial degeneration. Nat Cell Biol. 2008, 10: 1090-1097. 10.1038/ncb1769.PubMed CentralView ArticlePubMed
- Chernoff YO, Vincent A, Liebman SW: Mutations in eukaryotic 18 S ribosomal RNA affect translational fidelity and resistance to aminoglycoside antibiotics. EMBO J. 1994, 13: 906-913.PubMed CentralPubMed
- Hildebrandt JP, Plant TD, Meves H: The effects of bradykinin on K+ currents in NG108-15 cells treated with U73122, a phospholipase C inhibitor, or neomycin. Br J Pharmacol. 1997, 120: 841-850. 10.1038/sj.bjp.0700991.PubMed CentralView ArticlePubMed
- Wilmes G, Bergkessel M, Bandyopadhyay S, Shales M, Braberg H, Cagney G, Collins S, Whitworth G, Kress T, Weissman J: A genetic interaction map of RNA-processing factors reveals links between Sem1/Dss1-containing complexes and mRNA export and splicing. Mol Cell. 2008, 32: 735-746. 10.1016/j.molcel.2008.11.012.PubMed CentralView ArticlePubMed
- Gavin AC, Aloy P, Grandi P, Krause R, Boesche M, Marzioch M, Rau C, Jensen LJ, Bastuck S, Dümpelfeld B, Edelmann A, Heurtier MA, Hoffman V, Hoefert C, Klein K, Hudak M, Michon AM, Schelder M, Schirle M, Remor M, Rudi T, Hooper S, Bauer A, Bouwmeester T, Casari G, Drewes G, Neubauer G, Rick JM, Kuster B, Bork P: Proteome survey reveals modularity of the yeast cell machinery. Nature. 2006, 440: 631-636. 10.1038/nature04532.View ArticlePubMed
- Gavin AC, Bosche M, Krause R, Grandi P, Marzioch M, Bauer A, Schhultz J, Rick JM, Michon AM, Cruciat CM, Remor M, Höfert C, Schelder M, Brajenovic M, Ruffner H, Merino A, Klein K, Hudak M, Dickson D, Rudi T, Gnau V, Bauch A, Bastuck S, Huhse B, Leutwein C, Heurtier MA, Copley RR, Edelmann A, Querfurth E, Rybin V: Functional organization of the yeast proteome by systematic analysis of protein complexes. Nature. 2002, 415: 141-147. 10.1038/415141a.View ArticlePubMed
- Begley U, Dyavaiah M, Patil A, Rooney JP, DiRenzo D, Young CM, Conklin DS, Zitomer RS, Begley TJ: Trm9 catalyzed tRNA modifications link translation to the DNA damage response. Mol Cell. 2007, 28: 860-870. 10.1016/j.molcel.2007.09.021.PubMed CentralView ArticlePubMed
- Eisen MB, Spellman PT, Brown PO, Botstein D: Cluster analysis and display of genome-wide expression patterns. Proc Nat Acad Sc USA. 1998, 95: 14863-14868. 10.1073/pnas.95.25.14863.View Article
- Fourmy D, Recht MI, Puglisi JD: Binding of neomycin-class aminoglycoside antibiotics to the A-site of 16 s rRNA. J Mol Biol. 1998, 277: 347-362. 10.1006/jmbi.1997.1552.View ArticlePubMed
- Laughrea M: Speed-accuracy relationships during in vitro and in vivo protein biosynthesis. Biochimie. 1981, 63: 145-168. 10.1016/S0300-9084(81)80189-7.View ArticlePubMed
- Schuldiner M, Collins SR, Thompson NJ, Denic V, Bhamidipati A, Punna T, Ihmels J, Andrews B, Boone C, Greenblatt JF, Weissman JS, Krogan NJ: Exploration of the function and organization of the yeast early secretory pathway through an epistatic miniarray profile. Cell. 2005, 123: 507-519. 10.1016/j.cell.2005.08.031.View ArticlePubMed
- Costanzo M, Baryshnikova A, Bellay J, Kim Y, Spear ED, Sevier CS, Ding H, Koh JL, Toufighi K, Mostafavi S, Prinz J, St Onge RP, VanderSluis B, Makhnevych T, Vizeacoumar FJ, Alizadeh S, Bahr S, Brost RL, Chen Y, Cokol M, Deshpande R, Li Z, Lin ZY, Liang W, Marback M, Paw J, San Luis BJ, Shuteriqi E, Tong AH, van Dyk N: The genetic landscape of a cell. Science. 2010, 327: 425-431. 10.1126/science.1180823.View ArticlePubMed
- Kim TY, Ha CW, Huh WK: Differential subcellular localization of ribosomal protein L7 paralogs in Saccharomyces cerevisiae. Mol Cells. 2009, 27: 539-546. 10.1007/s10059-009-0077-0.View ArticlePubMed
- Mathur V, Hong JY, Liebman SW: Ssa1 overexpression and [PIN + ] variants cure [PSI+] by dilution of aggregates. J Mol Biol. 2009, 390: 155-167. 10.1016/j.jmb.2009.04.063.PubMed CentralView ArticlePubMed
- Krogan NJ, Kim M, Tong A, Golshani A, Cagney G, Canadien V, Richards DP, Beattie BK, Emili A, Boone C, Shilatifard A, Buratowski S, Greenblatt J: Methylation of histone H3 by Set2 in Saccharomyces cerevisiae is linked to transcriptional elongation by RNA polymerase II. Mol Cell Biol. 2003, 23: 4207-4218. 10.1128/MCB.23.12.4207-4218.2003.PubMed CentralView ArticlePubMed
- Stansfield I, Tuite MF: A mutant allele of the SUP45 (SAL4) gene of Saccharomyces cerevisiae shows temperature-dependent allosuppressor and omnipotent suppressor phenotypes. Curr Genet. 1995, 27: 417-426. 10.1007/BF00311210.View ArticlePubMed
- Vlásek L, Phan L, Schoenfeld LW, Valásková V, Hinnebusch AG: Related eIF3 subunits TIF32 and HCR1 interact with an RNA recognition motif in PRT1 required for eIF3 integrity and ribosome binding. EMBO J. 2001, 20: 891-904. 10.1093/emboj/20.4.891.View Article
- Kemmer D, McHardy LM, Hoon S, Rebérioux D, Giaever G, Nislow C, Roskelley CD, Roberge M: Combining chemical genomics screens in yeast to reveal spectrum of effects of chemical inhibition of sphingolipid biosynthesis. BMC Microbiol. 2009, 9: 9-10.1186/1471-2180-9-9.PubMed CentralView ArticlePubMed
- Roberts GG, Hudson AP: Transcriptome profiling of Saccharomyces cerevisiae during translation from fermentative to glycerol-based respiratory growth reveals extensive metabolic and structural remodeling. Mol Gen Genomics. 2006, 276: 170-186. 10.1007/s00438-006-0133-9.View Article
- Cullen PJ, Sabbagh W, Graham E, Irick MM, van Olden EK, Neal C, Delrow J, Bardwell L, Spraque JF: A signaling mucin at the head of the Cdc42- and MAPK-dependent filamentous growth pathway in yeast. Genes Dev. 2004, 18: 1695-1708. 10.1101/gad.1178604.PubMed CentralView ArticlePubMed
- Ganoza MC, Kiel MC, Aoki H: Evolutionary conservation of reactions in translation. Microbiol Mol Biol Rev. 2002, 66: 460-485. 10.1128/MMBR.66.3.460-485.2002.PubMed CentralView ArticlePubMed
- Fleischer TC, Weaver CM, McAfee KJ, Jennings JL, Link AJ: Systematic identification and functional screens of uncharacterized proteins associated with eukaryotic ribosomal complexes. Genes Dev. 2006, 20: 1294-1307. 10.1101/gad.1422006.PubMed CentralView ArticlePubMed
- Pitre S, North C, Alamgir M, Jessulat M, Chan A, Luo X, Green JR, Dumontier M, Dehne F, Golshani A: Global investigation of protein-protein interactions in yeast Saccharomyces cerevisiae using re-occurring short polypeptide sequences. Nucleic Acids Res. 2008, 36: 4286-94. 10.1093/nar/gkn390.PubMed CentralView ArticlePubMed
- Mnaimneh S, Davierwala AP, Haynes J, Moffat J, Peng W, Zhang W, Yang X, Pootoolal J, Chua G, Lopez A, Trochesset M, Morse D, Krogan NJ, Hiley SL, Li Z, Morris Q, Grigull J, Mitsakakis N, Roberts CJ, Greenblatt JF, Boone C, Kaiser CA, Andrews BJ, Hughes TR: Exploration of essential gene functions via titratable promoter alleles. Cell. 2004, 118: 31-44. 10.1016/j.cell.2004.06.013.View ArticlePubMed
- Ho Y, Gruhler A, Heilbut A, Bader GD, Moore L, Adams SL, Millar A, Taylor P, Bennett K, Boutilier K, Yang L, Wolting C, Donaldson I, Schandorff S, Shewnarane J, Vo M, Taggart J, Goudreault M, Muskat B, Alfarano C, Dewar D, Lin Z, Michalickova K, Willems AR, Sassi H, Nielsen PA, Rasmussen KJ, Andersen JR, Johansen LE, Hansen LH: Systematic identification of protein complexes in Saccharomyces cerevisiae by mass spectrometry. Nature. 2002, 415: 180-183. 10.1038/415180a.View ArticlePubMed
- Deutschbauer AM, Jaramillo DF, Proctor M, Kumm J, Hillenmeyer ME, Davis RW, Nislow C, Giaever G: Mechanisms of haploinsufficiency revealed by genome-wide profiling in yeast. Genetics. 2005, 169: 1915-1925. 10.1534/genetics.104.036871.PubMed CentralView ArticlePubMed
- Sherman F, Fink GR, Lawrence CW: Methods in yeast genetics: A laboratory manual. 1986, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY
- National committee for clinical laboratory standards: Reference method for broth dilution antifungal susceptibility testing of yeasts. 2002, NCCLS document M27-A2, NCCLS, Wayne, PA, Approved standard, 2
- Otsu N: A Threshold selection method from Gray-Level histograms. IEEE Transactions on Systems, Man, and Cybernetics. 1979, 9: 62-66. 10.1109/TSMC.1979.4310076.View Article
- Jessulat M, Alamgir M, Salsali H, Greenblatt J, Xu J, Golshani A: Interacting proteins Rtt109 and Vps75 affect the efficiency of non-homologous end-joining in Saccharomyces cerevisiae. Arch Biochem Biophys. 2008, 469: 157-164. 10.1016/j.abb.2007.11.001.View ArticlePubMed
- Gola S, Martin R, Walther A, Dünkler A, Wendland J: New modules for PCR-based gene targeting in Candida albicans: rapid and efficient gene targeting using 100 bp of flanking homology region. Yeast. 2003, 20: 1339-1347. 10.1002/yea.1044.View ArticlePubMed
- Goldstein AL, McCusker JH: Three new dominant resistance cassettes for gene disruption in Saccharomyces cerevisiae. Yeast. 1999, 15: 1541-1553. 10.1002/(SICI)1097-0061(199910)15:14<1541::AID-YEA476>3.0.CO;2-K.View ArticlePubMed
- Tong AHY, Lesage G, Bader GD, Ding H, Xu H, Xin X, Young J, Berriz GF, Brost RL, Chang M, Chen Y, Cheng X, Chua G, Friesen H, Goldberg DS, Haynes J, Humphries C, He G, Hussein S, Ke L, Krogan N, Li Z, Levinson JN, Lu H, Ménard P, Munyana C, Parsons AB, Ryan O, Tonikian R, Roberts T: Global mapping of the yeast genetic interaction network. Science. 2004, 303: 808-813. 10.1126/science.1091317.View ArticlePubMed
- Sopko R, Huang D, Preston N, Chua G, Papp B, Kafadar K, Snyder M, Oliver SG, Cyert M, Hughes TR, Boone C, Andrews B: Mapping pathways and phenotypes by systematic gene overexpression. Mol Cell. 2006, 21: 319-330. 10.1016/j.molcel.2005.12.011.View ArticlePubMed
- Lucchini G, Hinnebusch AG, Chen C, Fink GR: Positive regulatory interactions of the HIS4 gene of Saccharomyces cerevisiae. Mol Cell Biol. 1984, 4: 1326-1333.PubMed CentralView ArticlePubMed
- Shenton D, Smirnova JB, Selley JN, Carroll K, Hubbard SJ, Pavitt GD, Ashe MP, Grant CM: Global translational responses to oxidative stress impact upon multiple levels of protein synthesis. J Biol Chem. 2006, 281: 29011-29021. 10.1074/jbc.M601545200.View ArticlePubMed
- Schwartz DC, Parker R: Mutations in translation initiation factors lead to increased rates of deadenylation and decapping of mRNAs in Saccharomyces cerevisiae. Mol Cell Biol. 1999, 19: 5247-5256.PubMed CentralView ArticlePubMed
- Foiani M, Cigan AM, Paddon CJ, Harashima S, Hinnebusch AG: GCD2, a translational repressor of the GCN4 gene, has a general function in the initiation of protein synthesis in Saccharomyces cerevisiae. Mol Cell Biol. 1991, 11: 3203-3216.PubMed CentralView ArticlePubMed
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.